Skip to main content
. 2021 Jan 22;6(2):100656. doi: 10.1016/j.adro.2021.100656

Table 2.

Summary of the dosimetric parameters and planning time

Group 1
Group 2
Auto-plan Final plan P Auto-plan Final plan P
Breast/CW V95 (%) 97.5 ± 2.6 97.4 ± 2.6 .78 92.4 ± 6.6 92.3 ± 6.8 .45
Breast/CW PTVeval V95 (%) 93.2 ± 4.0 93.1 ± 4.0 .34 89.9 ± 7.9 89.6 ± 8.2 .37
SCL V90 (%) 97.0 ± 4.6 97.0 ± 4.6 .01
IMN V90 (%) 90.4 ± 17.9 93.4 ± 10.3 .08
Ax V90 (%) 92.1 ± 5.9 91.5 ± 6.2 .17
V105 (%) 11.5 ± 11.1 11.2 ± 9.9 .46 43.0 ± 26.3 39.4 ± 23.7 .01
V110 (%) 0.6 ± 4.6 0.4 ± 3.2 .31 6.5 ± 10 3.3 ± 9.7 <.01
Dmax (%) 109.2 ± 1.4 108.8 ± 1.5 .01 119.7 ± 9.5 114.4 ± 8.8 <.01
Heart Dmean (%) 1.7 ± 0.7 1.7 ± 0.7 .82 2.9 ± 1.7 2.9 ± 1.7 .07
Heart D5% (%) 5.0 ± 2.2 5.0 ± 2.2 .86 7.4 ± 4.5 7.3 ± 4.5 .76
Ipsilateral lung Dmean (%) 13.7 ± 6.0 13.7 ± 5.9 .99 31.8 ± 5.3 31.8 ± 5.3 .76
Ipsilateral lung D5% (%) 73.2 ± 27.4 73.3 ± 27.3 .55 88.4 ± 9.1 88.8 ± 9.2 .45
Planning time (min) 12.1 ± 9.3 13.1 ± 12.9 16.4 ± 9.7 26.4 ± 16.4
Total planning time (min) 25.7 ± 16.8 42.9 ± 20.3

Abbreviations: Ax = axillary node; CW = chest wall; IMN = internal mammary nodes; PTVeval = planning target volume for evaluation; RT = radiation therapy; SCL = supraclavicular nodes.